• In research and early development - in which disease area do we to seek an indication? How should we design our study?
• In Phase III+ – what is the best positioning for our product?
• At launch – how do we achieve optimal uptake in an already crowded marketplace?
• When a new competitor launches – how do we win on our terms?
• As your product matures (LCM) – how do we extend revenue generation and counter the generic threat?

Click here to view the latest job opportunities at Deallus Group.